ABVC (ABVC BioPharma) FCF Margin %: 0.00% (As of Mar. 2026)

What is ABVC BioPharma FCF Margin %?

ABVC BioPharma ABVC +2.43% 17 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates ABVC with a GF Score™ of 17/100 and a GF Value™ of $0.87 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, ABVC BioPharma ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ABVC BioPharma's Free Cash Flow for the three months ended in Mar. 2026 was $-0.89 Mil. ABVC BioPharma's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, ABVC BioPharma's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, ABVC BioPharma's current FCF Yield % is -8.71%.

The historical rank and industry rank for ABVC BioPharma's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of ABVC BioPharma was -354.71%. The lowest was -2768.42%. And the median was -859.99%.

ABVC's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

ABVC BioPharma FCF Margin % Related Terms

ABVC BioPharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for ABVC BioPharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ABVC BioPharma FCF Margin % Chart

ABVC BioPharma Annual Data

Trend

Sep16

Sep17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

-2,139.33

-775.05

-2,768.42

-354.71

0.00

ABVC BioPharma Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

ABVC vs GRDX, INMB, ALGS: FCF Margin % Comparison

For the Biotechnology subindustry, ABVC BioPharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ABVC BioPharma FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ABVC BioPharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ABVC BioPharma's FCF Margin % falls into.

Save Embed

17GF Score

ABVC BioPharma Inc ABVC

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

ABVC BioPharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ABVC BioPharma's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-2.986	/	0
	=	%

ABVC BioPharma's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-0.894	/	0
	=	%

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of 0.00% mean?

ABVC BioPharma (ABVC) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ABVC BioPharma and its competitors. According to the industry distribution chart, ABVC BioPharma ranks #999999 out of 959 companies in the Biotechnology industry.

Is ABVC BioPharma's FCF Margin % too high?

ABVC BioPharma's current FCF Margin % is 0.00%. Based on the distribution chart, ABVC BioPharma ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, ABVC BioPharma has a GF Score™ of 17/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does ABVC BioPharma's FCF Margin % compare to GRDX and INMB?

According to the Biotechnology industry distribution chart, ABVC BioPharma ranks #999999 out of 959 companies for FCF Margin %. This places ABVC BioPharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ABVC BioPharma and its competitors. ABVC BioPharma's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is ABVC BioPharma stock overvalued right now?

Based on GuruFocus' analysis, ABVC BioPharma (ABVC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.87, compared to a current price of $1.48 — trading 69.5% above its estimated fair value. The current FCF Margin % is 0.00%. ABVC BioPharma's overall GF Score™ is 17/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For ABVC BioPharma (ABVC), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ABVC BioPharma (ABVC) Overvalued in 2026?

Based on GuruFocus' analysis, ABVC BioPharma stock appears to be overvalued. The current stock price of $1.48 is trading 69.5% above its estimated GF Value™ of $0.87. GuruFocus considers ABVC BioPharma to be Significantly Overvalued.

Key valuation signals for ABVC:

FCF Margin %: 0.00%
GF Value™: $0.87 vs. price of $1.48 (69.5% above fair value)
GF Score™: 17/100 with 1 warning sign

No single metric tells the full story. See the ABVC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ABVC BioPharma Business Description

Industry Healthcare Biotechnology

Comparable Companies GRDX INMB ALGS VERU LITS ATNM DARE GRCE PSTV TVGN VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 44370 Old Warm Springs Boulevard, Fremont, CA, USA, 94538

Website https://www.abvcpharma.com

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

17GF Score

Get the complete analysis for ABVC

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.48

Price

$0.87

GF Value

View ABVC Analysis

See FCF Margin % data for all stocks →